Detalhe da pesquisa
1.
Utility of Oncotype DX in Male Breast Cancer Patients and Impact on Chemotherapy Administration: A Comparative Study with Female Patients.
Ann Surg Oncol
; 27(10): 3605-3611, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32472417
2.
Changing practice patterns of adjuvant radiation among elderly women with early stage breast cancer in the United States from 2004 to 2014.
Breast J
; 26(3): 353-367, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31538703
3.
Practice Changing Potential of TAILORx: A Retrospective Review of the National Cancer Data Base from 2010 to 2015.
Ann Surg Oncol
; 26(10): 3397-3408, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31429016
4.
Immunotherapy for Breast Cancer is Finally at the Doorstep: Immunotherapy in Breast Cancer.
Ann Surg Oncol
; 25(10): 2852-2857, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30014455
5.
Impact of Neoadjuvant Chemotherapy on Breast Cancer Subtype: Does Subtype Change and, if so, How? : IHC Profile and Neoadjuvant Chemotherapy.
Ann Surg Oncol
; 25(12): 3535-3540, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29981025
6.
Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged < 50 Years versus ≥ 50 Years, and Trends Over Time.
Ann Surg Oncol
; 25(10): 2875-2883, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-29959613
7.
The impact of preoperative magnetic resonance imaging and lumpectomy cavity shavings on re-excision rate in pure ductal carcinoma in situ-A single institution's experience.
J Surg Oncol
; 117(4): 558-566, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29127721
8.
Quality of life and sexual well-being after nipple sparing mastectomy: A matched comparison of patients using the breast Q.
J Surg Oncol
; 118(1): 238-242, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-30114323
9.
Evaluating the Risk of Upstaging HER2-Positive DCIS to Invasive Breast Cancer.
Ann Surg Oncol
; 24(10): 2999-3003, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28766212
10.
Anti-HER2 CD4+ T-Helper Type 1 Immune Response is Superior to Breast MRI for Assessing Response to Neoadjuvant Therapy in Patients with HER2-Positive Breast Cancer.
Ann Surg Oncol
; 24(4): 1057-1063, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27826664
11.
ASO Author Reflections: No Profiling in Male Breast Cancer: Where We are and Where We Should Be.
Ann Surg Oncol
; 27(10): 3612-3613, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32335751
12.
'Under' Surveillance: Impact of Race and Socioeconomic Status on Post-Treatment Breast Cancer Imaging.
Ann Surg Oncol
; 25(6): 1456-1457, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29516361
13.
Are We Overtreating Patients With T1a HER2+ Breast Cancer? An Analysis of the National Cancer Database.
Clin Breast Cancer
; 22(8): 828-839, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151019
14.
NSQIP Analysis of Axillary Lymph Node Dissection Rates for Breast Cancer: Implications for Resident and Fellow Participation.
J Surg Educ
; 75(5): 1281-1286, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29605705
15.
Restoring anti-oncodriver Th1 responses with dendritic cell vaccines in HER2/neu-positive breast cancer: progress and potential.
Immunotherapy
; 8(10): 1219-32, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27605070
16.
Restoring Lost Anti-HER-2 Th1 Immunity in Breast Cancer: A Crucial Role for Th1 Cytokines in Therapy and Prevention.
Front Pharmacol
; 7: 356, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27766079